[ad_1]
Confirming it had approved the AstraZeneca vaccine, the European Medicines Agency (EMA) said that most participants in the test studies were between 18 and 55 years old. It said that while there were not yet enough results to show how the vaccine will work in older people, “protection is expected, given that an immune response is seen in this age group and based on experience with other vaccines.”
[ad_2]
Source link
